Safety study of SYH9017 for overweight and obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medication called SYH9017 for people who are overweight or have obesity. It aims to see how safe the drug is, how well it is tolerated, and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old and overweight or have obesity (based on BMI).
- Your weight has not changed much (less than 5%) in the last 3 months.
- You are not using any weight-loss medications, antidepressants, or other drugs that could affect your weight.
- You do not have diabetes, thyroid problems, or a personal or family history of medullary thyroid cancer.
- You are willing to use effective non-hormonal birth control (and not plan to donate sperm/eggs) for 6 months after the study ends.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational weight-loss medication (MDR-001) for people who are overweight or have obesity. Researchers want to see if this drug helps with weight loss and is safe when taken along with diet and exercise.
This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.
This study tests a new medication called HS-20094 for people who are overweight or have obesity. It is designed to help with weight loss and will last for several months to see how safe and effective the medicine is.
This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.
This trial tests an investigational drug called BGM1812 given as an injection. It is for healthy Chinese adults who are either at a normal weight or are overweight/obese but not diabetic. The study will see how the drug works in the body and check for side effects.
This trial tests a new oral medication (GZC8072) in two groups: healthy people given a single dose, and people who are overweight or obese given multiple doses. The study aims to see if the drug is safe and how the body handles it, and may help with weight management.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.